These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1206104)

  • 1. Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.
    Gerich JE; Tsalikian E; Lorenzi M; Schneider V; Bohannon NV; Gustafson G; Karam JH
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1178-80. PubMed ID: 1206104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of plasma glucagon response to arginine after treatment in patients with diabetes mellitus, cushing's syndrome and hypothyroidism.
    Seino Y; Goto Y; Kurahachi H; Sakurai H; Ikeda M
    Horm Metab Res; 1977 Jan; 9(1):28-32. PubMed ID: 844789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier J; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes.
    Lawecki J; Symonides-Lawecka A; Rogala H
    Pol Med Sci Hist Bull (1973); 1976; 15(2):177-82. PubMed ID: 959042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal glucagon response to arginine infusion in "prediabetic" Pima Indians.
    Aronoff SL; Bennett PH; Rushforth NB; Miller M; Unger RH
    J Clin Endocrinol Metab; 1976 Aug; 43(2):279-86. PubMed ID: 950363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma glucagon and insulin concentrations in acromegaly.
    Trimble ER; Atkinson AB; Buchanan KD; Hadden DR
    J Clin Endocrinol Metab; 1980 Sep; 51(3):626-31. PubMed ID: 6997331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xylitol: stimulation of insulin and inhibition of glucagon responses to arginine in man.
    Seino Y; Taminato T; Inoue Y; Goto Y; Ikeda M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):736-43. PubMed ID: 1262446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine-stimulated hyperglucagonemia in diabetic Pima Indians.
    Aronoff SL; Bennett PH; Rushforth NB; Miller M; Unger RH
    Diabetes; 1976 May; 25(5):404-7. PubMed ID: 1269839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute insulin withdrawal and administration on plasma glucagon responses to intravenous arginine in insulin-dependent diabetic subjects.
    Gerich JE; Lorenzi M; Tsalikian E; Bohannon NV; Schneider V; Karam JH; Forsham PH
    Diabetes; 1976 Oct; 25(10):955-60. PubMed ID: 976604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
    Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
    Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon response to arginine after treatment of diabetes mellitus.
    Ohneda A; Ishii S; Horigome K; Yamagata S
    Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exaggerated glucagon secretion in diabetic and non-diabetic subjects with surgical porto-caval anastomosis.
    Fallucca F; Ziparo V; Giangrande L; Menzinger G; Stipa S
    Horm Metab Res; 1981 Oct; 13(10):545-7. PubMed ID: 7298009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.